Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
491 days ago
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
748 days ago
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
848 days ago
European Shares Rise As Bond Yields Ease
European stocks edged higher on Wednesday as bond yields eased after the release of softer-than-expected U.S. producer inflation data.
RTTNews
|
5h 28min ago
Asian Shares Muted Ahead Of US CPI Data
Asian stocks ended little changed on Wednesday after reports emerged that U.S. President-elect Donald Trump's economic advisers are discussing slowly ramping up tariffs month by month.
RTTNews
|
5h 50min ago
Pound Slides Against Majors
The British pound weakened against other major currencies in the pre-European session on Wednesday.
RTTNews
|
6h 30min ago
Yen Rises As BoJ Governor Ueda Signals Rate Hike
The Japanese yen strengthened against other major currencies in the Asian session on Wednesday, after Bank of Japan Governor Kazuo Ueda signaled raising interest rates at next week's meeting.
RTTNews
|
7h 13min ago
European Economic News Preview: UK Inflation Data Due
Consumer and producer prices from the UK and industrial production from the euro area are the top economic news due on Wednesday. At 2.00 am ET, the Office for National Statistics releases UK consumer and producer prices for December. Inflation is forecast to remain unchanged at 2.6 percent.
Economists forecast output prices to remain flat on year, following a 0.6 percent drop in November.
RTTNews
|
7h 46min ago
